GenoPalate is a company that claims to give "personalized" dietary recommendations based on DNA testing. Unfortunately, what is provided by such companies is more akin to astrology than science.
The FDA says there's no good evidence that thermography can reliably screen for breast cancer or any other disease. Instead of pursuing the unlawful promotion of thermography for breast cancer detection on a case-by-case basis, the FDA should pull the plug on thermographic devices.
uBiome claims that its SmartJane test's proprietary technology empowers customers to assess their own vaginal health. The company is being investigated for fraudulent billing practices, and the rationale for the test makes no sense.
A chiropractor is using questionable diagnostic and therapeutic measures to return athletes to play sooner after a concussion. Not a good idea.
Experts review the evidence and find that common CAM lab tests have "little or no clinical benefit" and are "a potential risk to patient safety." Regulatory reform is urgently needed to protect the public.
Kidney cancer diagnoses are increasing but there has been no increase in mortality or rate of metastases. Kidney cancer is most often diagnosed as an incidental finding on a CT scan that was done for unrelated reasons. Treatment may not always be needed.
Osteoporosis is routinely treated with bisphosphonates to prevent fractures. A new study suggests that osteopenia should be treated too. But questions remain.